Self-reported olfactory and gustatory dysfunction in patients with COVID-19 infection

D. Kooper, H. Coerts, H. Mkadmi
{"title":"Self-reported olfactory and gustatory dysfunction in patients with COVID-19 infection","authors":"D. Kooper, H. Coerts, H. Mkadmi","doi":"10.4193/rhinol/20.088","DOIUrl":null,"url":null,"abstract":"Objective: To investigate the incidence, comorbidity and recovery period of smell and taste loss in patients with COVID-19 infection, who were treated as outpatient or admitted to the hospital. Methods: 103 patients with COVID-19 infection were recruited from a COVID-19 Test Centre (CTC) and hospital wards. Subjects filled in an online self-report survey retrospectively at least six months after recruitment. The following epidemiological and clinical outcomes have been studied: age, gender, comorbidities, general and otolaryngological symptoms and recovery of the olfactory or gustatory loss. Results: All patients suffered from mild to severe respiratory disease. A high frequency of smell and taste dysfunctions was reported (71.2% and 78.9% respectively). 33% of the patients reported anosmia and 33% reported ageusia. The most frequent symptoms were fever, loss of smell and taste, dyspnoea and headache. The most common comorbidities were hypertension, obesity and diabetes. Males suffered 2.6 times more often from olfactory dysfunction than females. No statistical difference with regard to recovery time were found between man and women. There was a significant difference in the sense of taste scores before COVID-19 infection and during COVID-19 infection. Smell and taste dysfunction was related to clinical course of the infection. There was no difference in recovery of smell and taste recovery between CTC, ward and ICU patients. 87.2% of the patients reported to have recovered from their smell and taste dysfunctions after 4 months. Parosmia after recovery of loss of smell has been reported by 13% of the patients. Conclusion: After 4 months, 87% of the patients with COVID-19 infection had recovered from their smell and taste loss. The smell dysfunction was related to the clinical course of the disease but it seems that there is no difference in recovery time of smell dysfunction between patients with severe and critical course disease.","PeriodicalId":74737,"journal":{"name":"Rhinology online","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rhinology online","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4193/rhinol/20.088","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Objective: To investigate the incidence, comorbidity and recovery period of smell and taste loss in patients with COVID-19 infection, who were treated as outpatient or admitted to the hospital. Methods: 103 patients with COVID-19 infection were recruited from a COVID-19 Test Centre (CTC) and hospital wards. Subjects filled in an online self-report survey retrospectively at least six months after recruitment. The following epidemiological and clinical outcomes have been studied: age, gender, comorbidities, general and otolaryngological symptoms and recovery of the olfactory or gustatory loss. Results: All patients suffered from mild to severe respiratory disease. A high frequency of smell and taste dysfunctions was reported (71.2% and 78.9% respectively). 33% of the patients reported anosmia and 33% reported ageusia. The most frequent symptoms were fever, loss of smell and taste, dyspnoea and headache. The most common comorbidities were hypertension, obesity and diabetes. Males suffered 2.6 times more often from olfactory dysfunction than females. No statistical difference with regard to recovery time were found between man and women. There was a significant difference in the sense of taste scores before COVID-19 infection and during COVID-19 infection. Smell and taste dysfunction was related to clinical course of the infection. There was no difference in recovery of smell and taste recovery between CTC, ward and ICU patients. 87.2% of the patients reported to have recovered from their smell and taste dysfunctions after 4 months. Parosmia after recovery of loss of smell has been reported by 13% of the patients. Conclusion: After 4 months, 87% of the patients with COVID-19 infection had recovered from their smell and taste loss. The smell dysfunction was related to the clinical course of the disease but it seems that there is no difference in recovery time of smell dysfunction between patients with severe and critical course disease.
新冠肺炎感染患者自我报告的嗅觉和味觉功能障碍
目的:了解新冠肺炎感染门诊或住院患者嗅觉和味觉丧失的发生率、合并症和恢复期。方法:从新冠肺炎检测中心(CTC)和医院病房招募103名新冠肺炎感染者。受试者在招募后至少六个月回顾性地填写了一份在线自我报告调查。研究了以下流行病学和临床结果:年龄、性别、合并症、一般和耳鼻喉科症状以及嗅觉或味觉丧失的恢复。结果:所有患者均患有轻度至重度呼吸道疾病。嗅觉和味觉功能障碍的发生率较高(分别为71.2%和78.9%)。33%的患者报告嗅觉缺失,33%报告老年痴呆。最常见的症状是发烧、嗅觉和味觉丧失、呼吸困难和头痛。最常见的合并症是高血压、肥胖和糖尿病。男性嗅觉功能障碍的发生率是女性的2.6倍。男性和女性在恢复时间方面没有发现统计学差异。新冠肺炎感染前和新冠肺炎感染期间的味觉评分存在显著差异。嗅觉和味觉功能障碍和感染的临床过程有关。CTC、病房和ICU患者的嗅觉和味觉恢复没有差异。87.2%的患者在4个月后从嗅觉和味觉功能障碍中恢复。据报道,13%的患者在嗅觉丧失后出现味觉减退。结论:4个月后,87%的新冠肺炎感染者已从嗅觉和味觉丧失中恢复。嗅觉功能障碍与疾病的临床病程有关,但重症和危重症患者的嗅觉功能障碍恢复时间似乎没有差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信